CLIKX® Tympanostomy Tube Delivery System for the Placement of Tympanostomy Tubes
for Otitis Media
Sites in Mesquite +1 more location
Sponsor: ClinQure, Inc.
Sex: All·Age: 6 Months+
Code: NCT07625657·Recruiting·Listed Jun 2026
Paid Clinical Trials in Mesquite, TX
As of September 2026, 61 paid clinical trials are recruiting in Mesquite, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
57 clinical trials
Get a weekly email when new trials open in Mesquite, TX.
A Study to Assess the Safety, Tolerability and Efficacy of ION775
for Hypertriglyceridemia
Sites in Mesquite, McKinney +14 more locations
Sponsor: Ionis Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT07604974·Phase 2·Recruiting·Listed May 2026
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
for Irritable Bowel Syndrome
Sites in Mesquite, Corsicana +108 more locations
Sponsor: GlaxoSmithKline
Sex: All·Age: 18 - 80
Code: NCT07519395·Phase 2·Recruiting·Listed Apr 2026
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
for Rheumatoid Arthritis
Drug: AZD1163
Sites in Mesquite, Austin +20 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT07276581·Phase 2·Recruiting·Listed Dec 2025
Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
for Rheumatoid Arthritis
Sites in Mesquite, Allen +2 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18 - 65
Code: NCT07201558·Phase 1·Recruiting·Listed Oct 2025
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
for Pulmonary Disease, Chronic Obstructive
Drug: Depemokimab
Sites in Mesquite, Dallas +40 more locations
Sponsor: GlaxoSmithKline
Sex: All·Age: 40 - 75
Code: NCT07177339·Phase 3·Recruiting·Listed Sep 2025
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
for Heart Failure
Drug: Dapagliflozin
Sites in Mesquite, Dallas +169 more locations
Sponsor: AstraZeneca
Sex: All·Age: 40+
Code: NCT06677060·Phase 3·Recruiting·Listed Nov 2024
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
for Cardiovascular Disease
Drug: AZD0780
Sites in Mesquite, Dallas +308 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT07000357·Phase 3·Recruiting·Listed Jun 2025
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
for Chronic Obstructive Pulmonary Disease (COPD)
Sites in Mesquite, Lewisville +60 more locations
Sponsor: AstraZeneca
Sex: All·Age: 40 - 80
Code: NCT06878261·Phase 3·Recruiting·Listed Mar 2025
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
for Graves' Disease
Drug: IMVT-1402
Sites in Mesquite, Dallas +53 more locations
Sponsor: Immunovant Sciences GmbH
Sex: All·Age: 18 - 75
Code: NCT06727604·Phase 2·Recruiting·Listed Dec 2024
Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease
for APOL1-Mediated Kidney Disease
Sites in Mesquite, Dallas +76 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18 - 65
Code: NCT06824987·Phase 2·Recruiting·Listed Feb 2025
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
for Chickenpox
Sites in Mesquite, Dallas +48 more locations
Sponsor: GlaxoSmithKline
Sex: All·Age: 12 Months - 15 Months·Accepts healthy volunteers
Code: NCT06740630·Phase 3·Recruiting·Listed Dec 2024